Do you or someone you know take a prescription drug to help with an “off-label”, or non-FDA approved, condition? This is a legal and common practice where doctors can prescribe medicines for treating less common conditions. Yet, until recently, Medicare denied coverage of these drugs.
On February 11, 2022, however, the U.S. Court of Appeals for the 11th Circuit reversed a lower-court decision and found that Medicare must provide coverage for a beneficiary’s off-label use of a medication in Dobson v. Secretary of Health & Human Services, No. 20-11996, 2022 WL 424813 (11th Cir. Feb. 11, 2022). This is great news!
We are grateful to the great advocacy work of our partners at Center for Medicare Advocacy in this victory.
For more information and details, read their recent article on this victory and the legal case that brought it about.